These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33664239)

  • 1. Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer.
    Weeks SE; Kammerud SC; Metge BJ; AlSheikh HA; Schneider DA; Chen D; Wei S; Mobley JA; Ojesina AI; Shevde LA; Samant RS
    Cell Death Dis; 2021 Mar; 12(3):242. PubMed ID: 33664239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
    Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
    Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt signaling in triple negative breast cancer is associated with metastasis.
    Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
    BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt/β-Catenin Pathway is Activated as a Novel Nucleolar Stress Response.
    Dannheisig DP; Bächle J; Tasic J; Keil M; Pfister AS
    J Mol Biol; 2021 Jan; 433(2):166719. PubMed ID: 33221336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt/β-catenin signaling.
    Peng J; Liu X; Mao Y; Lv M; Ma T; Liu J; Zhou Q; Han Y; Li X; Wang H
    Mol Carcinog; 2024 Aug; 63(8):1588-1598. PubMed ID: 38780151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
    Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer.
    Ryu WJ; Lee JD; Park JC; Cha PH; Cho YH; Kim JY; Sohn JH; Paik S; Choi KY
    Exp Mol Med; 2020 May; 52(5):832-842. PubMed ID: 32457491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT; Tseng LM; Chen JL; Chu PY; Lee CH; Huang CT; Wang WL; Lau KY; Tseng MF; Chang YY; Chiang TY; Ueng YF; Lee HC; Dai MS; Liu CY
    EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    Fatima I; El-Ayachi I; Taotao L; Lillo MA; Krutilina RI; Seagroves TN; Radaszkiewicz TW; Hutnan M; Bryja V; Krum SA; Rivas F; Miranda-Carboni GA
    PLoS One; 2017; 12(12):e0189864. PubMed ID: 29281678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
    Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
    Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in ADAR1p110 activates the canonical Wnt signaling pathway associated with aggressive phenotype in triple negative breast cancer cells.
    Morales F; Pérez P; Tapia JC; Lobos-González L; Herranz JM; Guevara F; de Santiago PR; Palacios E; Andaur R; Sagredo EA; Marcelain K; Armisén R
    Gene; 2022 Apr; 819():146246. PubMed ID: 35122924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.
    Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
    Cancer Lett; 2018 Dec; 438():165-173. PubMed ID: 30227220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
    Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
    Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin.
    Shen H; Yan W; Yuan J; Wang Z; Wang C
    J Exp Clin Cancer Res; 2019 Jun; 38(1):243. PubMed ID: 31174562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer.
    Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H
    J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
    Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
    Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer.
    Alraouji NN; Al-Mohanna FH; Ghebeh H; Arafah M; Almeer R; Al-Tweigeri T; Aboussekhra A
    Mol Carcinog; 2020 Sep; 59(9):1041-1051. PubMed ID: 32537818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
    Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
    BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinesin family member 23, regulated by FOXM1, promotes triple negative breast cancer progression via activating Wnt/β-catenin pathway.
    Li Z; Yang HY; Zhang XL; Zhang X; Huang YZ; Dai XY; Shi L; Zhou GR; Wei JF; Ding Q
    J Exp Clin Cancer Res; 2022 May; 41(1):168. PubMed ID: 35524313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.